Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise push
Daiichi Sankyo is betting on its oncology franchise to push it past 3 trillion Japanese yen ($19 billion) in 2030 revenues. The drugmaker published a new five-year business plan on Monday ...
May 11, 2026 11:35 AM EDT R&DPharma Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise push Ayisha Sharma News Reporter Daiichi Sankyo is betting on its oncology franchise to push it past 3 trillion Japanese yen ($19 billion) in 2030 revenues. The drugmaker published a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that